HIV Research & Clinical Practice, Volume 18, Issue 4 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Clinical Trials, Volume 18, Issue 4 (2017)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Volume 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Original Article

Article
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI
Anton Pozniak, Jason Flamm, Andrea Antinori, Mark Bloch, Douglas Ward, Juan Berenguer, Pierre Cote, Kristen Andreatta, William Garner, Javier Szwarcberg, Thai Nguyen-Cleary, Damian J. McColl & David Piontkowsky
Pages: 141-148
Published online: 09 Jul 2017
AbstractforSwitching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI | Full Text | References | PDF (660.3 KB) | Supplemental
  • 651 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access
Article
The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates
Mark J. Siedner, Mwebesa B. Bwana, Mahomed-Yunus S. Moosa, Michelle Paul, Selvan Pillay, Suzanne McCluskey, Isaac Aturinda, Kevin Ard, Winnie Muyindike, Pravikrishnen Moodley, Jaysingh Brijkumar, Tamlyn Rautenberg, Gavin George, Brent Johnson, Rajesh T. Gandhi, Henry Sunpath & Vincent C. Marconi
Pages: 149-155
Published online: 18 Jul 2017
AbstractforThe REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates | Full Text | References | PDF (869.7 KB) | Supplemental
  • 861 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection
Sahera Dirajlal-Fargo, Abdus Sattar, Manjusha Kulkarni, Nicholas Funderburg & Grace A. McComsey
Pages: 156-163
Published online: 22 Aug 2017
AbstractforSoluble TWEAK may predict carotid atherosclerosis in treated HIV infection | Full Text | References | PDF (497.1 KB)
  • 340 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128)
Rima Kulkarni, Sally L. Hodder, Huyen Cao, Silvia Chang, Michael D. Miller & Kirsten L. White
Pages: 164-173
Published online: 11 Sep 2017
AbstractforWeek 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128) | Full Text | References | PDF (308.8 KB) | Supplemental
  • 283 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Letter to the Editor

Letter
Will CURE trials introduce an uncomfortable revolution in the field of HIV research?
Christel Protière, Marie Préau, Marjolaine Doumergue, Marion Mora, Olivier Lambotte, Bruno Spire & Marie Suzan-Monti
Pages: 174-175
Published online: 06 Jun 2017
CitationforWill CURE trials introduce an uncomfortable revolution in the field of HIV research? | Full Text | References | PDF (231.9 KB)
  • 336 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Explore articles